Glanzmann thrombasthenia
Information
- Disease name
- Glanzmann thrombasthenia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03333486 | Active, not recruiting | Phase 2 | Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer | December 7, 2017 | August 28, 2024 |
| NCT04595617 | Completed | N/A | Anti-αIIbβ3 Immunization in Glanzmann Thrombasthenia: Prevalence and Associated Risk Factors: Thrombasthenia Anti-αIIbβ3 Antibodies Study (TAAS) | January 6, 2021 | July 6, 2023 |
| NCT05315232 | Completed | The Experiences of People Who Live With Glanzmanns Thrombasthenia. | April 27, 2022 | April 27, 2023 | |
| NCT06234813 | Completed | N/A | Targeting TFPI With Concizumab to Improve Haemostasis in Glanzmann Thrombasthenia Patients: an in Vitro Study | April 6, 2023 | July 17, 2023 |
| NCT01917708 | Completed | Phase 1 | Bone Marrow Transplant With Abatacept for Non-Malignant Diseases | January 2014 | September 19, 2019 |
| NCT06204042 | Not yet recruiting | Multinational Glanzmann Study | March 1, 2024 | March 1, 2029 | |
| NCT00230165 | Recruiting | The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders. | September 2005 | June 2024 | |
| NCT02179359 | Recruiting | N/A | Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies | September 2, 2014 | August 2025 |
| NCT04119908 | Recruiting | N/A | Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases | May 24, 2023 | May 24, 2028 |
| NCT06211634 | Recruiting | Phase 1/Phase 2 | A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia | December 13, 2022 | February 28, 2026 |
| NCT01319851 | Terminated | N/A | Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation | September 2010 | September 2013 |
| NCT04548791 | Terminated | Phase 1/Phase 2 | Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders | May 17, 2021 | December 3, 2021 |
- OrphaNumber from OrphaNet (Orphanet)
- 849